If you need any product or service please register as the Farmavita.Net network member and publish your needs. License-in is very cost effective way of product development. In the most of the licensing cases you will pay only share of total development cost for the pharmaceutical product. Published license-out opportunities are alphabetically listed according to pharmaceutical INN name. Please choose the category below:

Epoprostenol

Popular Sale

Description



Member of Farmavita:net offer Dossier and license for Epoprostenol


CTD with supply agreement and marketing authorization


Epoprostenol 0.5 mg and 1.5 mg (Powder and Solvent for Solution for Infusion)


Epoprostenol is indicated for:

Pulmonary Arterial Hypertension
Epoprostenol is indicated for the treatment of pulmonary arterial hypertension (PAH) (idiopathic or heritable PAH and PAH ociated with connective tissue diseases) in patients with WHO Functional Cl III-IV symptoms to improve exercise capacity.


Renal Dialysis
Epoprostenol is indicated for the use in haemodialysis in emergency situations when use of heparin carries a high risk of causing or exacerbating bleeding or when heparin is otherwise contraindicated.





 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 973

Advertiser details

+4xxx xxxxx show
Contact Advertiser

Add comment

 
Related adverts
 

Phone number

Sorry, you need to register or login first.

Email

Sorry, you need to register or login first.

Epoprostenol

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favorites

Sorry, you need to register or login first.

Advert search